Eyenovia Inc
NASDAQ:EYEN
Balance Sheet
Balance Sheet Decomposition
Eyenovia Inc
Current Assets | 20.7m |
Cash & Short-Term Investments | 14.8m |
Receivables | 624.5k |
Other Current Assets | 5.2m |
Non-Current Assets | 8.1m |
PP&E | 5m |
Intangibles | 2.1m |
Other Non-Current Assets | 908.6k |
Current Liabilities | 9.5m |
Accounts Payable | 1.8m |
Accrued Liabilities | 2.4m |
Other Current Liabilities | 5.4m |
Non-Current Liabilities | 10.2m |
Long-Term Debt | 9m |
Other Non-Current Liabilities | 1.3m |
Balance Sheet
Eyenovia Inc
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
2
|
3
|
5
|
20
|
14
|
28
|
19
|
23
|
15
|
|
Cash |
2
|
3
|
5
|
20
|
14
|
28
|
19
|
23
|
15
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
2
|
1
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
8
|
3
|
5
|
|
Total Current Assets |
3
|
3
|
5
|
20
|
14
|
33
|
30
|
28
|
21
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Total Assets |
3
N/A
|
3
+22%
|
6
+64%
|
20
+255%
|
15
-27%
|
34
+131%
|
32
-7%
|
31
-2%
|
29
-7%
|
|
Liabilities | ||||||||||
Accounts Payable |
0
|
0
|
0
|
2
|
2
|
1
|
2
|
1
|
2
|
|
Accrued Liabilities |
0
|
0
|
0
|
2
|
1
|
3
|
2
|
3
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
5
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
0
|
1
|
3
|
3
|
18
|
11
|
5
|
10
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
9
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Liabilities |
0
N/A
|
0
N/A
|
1
+31%
|
3
+471%
|
3
-6%
|
19
+528%
|
11
-40%
|
14
+23%
|
20
+43%
|
|
Equity | ||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
11
|
14
|
19
|
37
|
58
|
77
|
90
|
118
|
145
|
|
Additional Paid In Capital |
13
|
17
|
24
|
53
|
69
|
93
|
111
|
135
|
154
|
|
Total Equity |
2
N/A
|
3
+25%
|
5
+69%
|
17
+232%
|
12
-30%
|
15
+30%
|
20
+34%
|
17
-16%
|
9
-48%
|
|
Total Liabilities & Equity |
3
N/A
|
3
+22%
|
6
+64%
|
20
+255%
|
15
-27%
|
34
+131%
|
32
-7%
|
31
-2%
|
29
-7%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
10
|
10
|
10
|
11
|
17
|
25
|
28
|
37
|
46
|